Siga Technologies INC Payments of Debt Issuance Costs
Siga Technologies INC (SIGA) reported Payments of Debt Issuance Costs of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2019-03-06
- Siga Technologies INC payments of debt issuance costs for the quarter ending 2012-12-31 was $386.00K.
- Siga Technologies INC payments of debt issuance costs for fiscal 2018 was $0.00.
- Siga Technologies INC payments of debt issuance costs for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Siga Technologies INC payments of debt issuance costs for fiscal 2016 was $3.78M.
- Siga Technologies INC payments of debt issuance costs for fiscal 2015 was $0.00.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-06 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-06 | |
| 2016-12-31 | $3.78M 10-K · filed 2019-03-06 | |
| 2015-12-31 | $0.00 10-K · filed 2018-03-06 | |
| 2014-12-31 | $0.00 10-K · filed 2017-03-07 | |
| 2012-12-31 | $386.00K 10-K/A · filed 2013-05-15 | $386.00K 10-K · filed 2015-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |